Showing results (1-10 of 44) with videos related to
Sort By:
Pageof 5
Expert Opinion on Pharmacotherapy|December 17, 2013
Protein kinase inhibitors in renal cell carcinomaAmaury Daste, Thomas Grellety, Marine Gross-Goupil, et al.Immunotherapy|December 21, 2023
Immunotherapy for head and neck squamous cell carcinoma: current status and perspectivesAmaury Daste, Mathieu Larroquette, Nyere Gibson, et al.Immunotherapy|April 28, 2021
Colitis presenting 5 months after the final dose of anti-PD-1: long-term monitoring is warranted after adjuvant therapyCharlotte Domblides, Marine Gross-Goupil, Alain Ravaud, et al.Targeted Oncology|January 4, 2013
Prolonged efficacy of mTOR inhibitors in papillary renal cell carcinoma: progression-free survival lasting for over 3 years, a case report and review of the literatureAmaury Daste, Marine Gross-Goupil, Sophie Roca, et al.Current Opinion in Oncology|March 30, 2021
Systemic treatment of metastatic squamous cell carcinoma of the head and neck: proposal for management changesFrédéric Peyrade, Christian Borel, Amaury Daste, et al.Expert Opinion on Biological Therapy|July 10, 2019
Which place for avelumab in the management of urothelial carcinoma?Mathieu Larroquette, Marine Gross-Goupil, Amaury Daste, et al.Bulletin Du Cancer|August 15, 2012
[Therapeutic strategies and systemic treatment of brain melanoma metastases]Xavier Durando, Sandrine Mansard, Amaury Daste, et al.BMC Cancer|May 13, 2017
Metastatic non-muscle invasive bladder cancer with meningeal carcinomatosis: case report of an unexpected responseDiego Teyssonneau, Amaury Daste, Vincent Dousset, et al.European Journal of Cancer (Oxford, England : 1990)|November 18, 2016
Targeted therapy and elderly people: A reviewAmaury Daste, Camille Chakiba, Charlotte Domblides, et al.Clinical Interventions in Aging|April 30, 2013
Optimal management of renal cell carcinoma in the elderly: a reviewAmandine Quivy, Amaury Daste, Asma Harbaoui, et al.Pageof 5